Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 20 | 50↑142.7% | 110↑122.3% | 164↑48.7% | 203↑23.9% |
| Gross Profit | 11 | 36↑226.6% | 88↑141.5% | 135↑54.4% | 166↑22.9% |
| Operating Income | -84 | -115↓37.8% | -82↑28.8% | -44↑46.3% | -34↑23.5% |
| Net Income | -91 | -123↓34.7% | -95↑22.9% | -62↑34.2% | -55↑11.9% |
| EBITDA | -79 | -114↓43.7% | -69↑39.0% | -24↑65.8% | -14↑41.0% |
| EPS Diluted | -2.14 | -1.55↑27.6% | -0.70↑54.8% | -0.45↑35.7% | -0.37↑17.8% |